SC-Ad6-1

· Moat Biotechnology Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SC-Ad6-1, covering 2025-08-21 to 2025-08-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers [Phase 1]